Edwards Lifesciences Corp (EW)
88.61
+0.86
(+0.98%)
USD |
NYSE |
Apr 24, 16:00
87.15
-1.46
(-1.65%)
Pre-Market: 20:00
Edwards Lifesciences Market Cap: 53.28B for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 53.28B |
| April 23, 2024 | 52.76B |
| April 22, 2024 | 52.29B |
| April 19, 2024 | 51.68B |
| April 18, 2024 | 51.98B |
| April 17, 2024 | 52.46B |
| April 16, 2024 | 54.15B |
| April 15, 2024 | 53.64B |
| April 12, 2024 | 54.29B |
| April 11, 2024 | 54.96B |
| April 10, 2024 | 55.02B |
| April 09, 2024 | 55.95B |
| April 08, 2024 | 55.52B |
| April 05, 2024 | 55.74B |
| April 04, 2024 | 54.84B |
| April 03, 2024 | 55.93B |
| April 02, 2024 | 56.71B |
| April 01, 2024 | 56.67B |
| March 28, 2024 | 57.46B |
| March 27, 2024 | 57.21B |
| March 26, 2024 | 56.17B |
| March 25, 2024 | 56.02B |
| March 22, 2024 | 56.40B |
| March 21, 2024 | 56.93B |
| March 20, 2024 | 55.94B |
| Date | Value |
|---|---|
| March 19, 2024 | 56.71B |
| March 18, 2024 | 55.83B |
| March 15, 2024 | 55.51B |
| March 14, 2024 | 56.14B |
| March 13, 2024 | 55.88B |
| March 12, 2024 | 54.66B |
| March 11, 2024 | 54.62B |
| March 08, 2024 | 55.40B |
| March 07, 2024 | 56.41B |
| March 06, 2024 | 53.11B |
| March 05, 2024 | 51.77B |
| March 04, 2024 | 52.33B |
| March 01, 2024 | 51.24B |
| February 29, 2024 | 51.03B |
| February 28, 2024 | 51.71B |
| February 27, 2024 | 52.02B |
| February 26, 2024 | 51.80B |
| February 23, 2024 | 52.76B |
| February 22, 2024 | 52.69B |
| February 21, 2024 | 52.10B |
| February 20, 2024 | 52.25B |
| February 16, 2024 | 51.77B |
| February 15, 2024 | 51.74B |
| February 14, 2024 | 51.74B |
| February 13, 2024 | 51.87B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
32.60B
Minimum
Mar 23 2020
81.59B
Maximum
Dec 30 2021
53.19B
Average
51.05B
Median
Mar 12 2021
Market Cap Benchmarks
| Stryker Corp | 128.09B |
| Boston Scientific Corp | 106.97B |
| Align Technology Inc | 23.57B |
| Abbott Laboratories | 185.47B |
| Steris PLC | 20.04B |
Market Cap Related Metrics
| PE Ratio | 38.53 |
| PS Ratio | 8.993 |
| Price to Book Value | 8.012 |
| Price to Free Cash Flow | 85.78 |
| Price | 88.61 |
| Earnings Yield | 2.60% |
| Operating PE Ratio | 31.22 |
| Normalized PE Ratio | 34.56 |